Ground-breaking
research.
The Foundation on the frontline
We’re funding the future
Discoveries from past decades determine the way our kids are cared for right now. Perth Children’s Hospital Foundation and our generous donors fund researchers and research projects that will transform the future of child health.
We bring clinicians closer who are the best in their fields and support the translation of projects into clinical practice and fund prevention and early intervention research that drastically improves kid’s lives.
In 2018/19 we provided over $2.5 million in research grants: a new milestone. We fund clinical-based studies that focus on specialist areas of paediatric health to pioneer new ways of preventing, treating and curing life-limiting and life-threatening illnesses and conditions.
If you are interested in learning more or applying for one of our research grants, click here.
Perth Children's Hospital is the sole centre for treatment of children with cancer in Western Australia. Currently, over 100 new cases are diagnosed every year.
Closer to new ways of thinking
Dr Nick Gottardo is the remarkable man working tirelessly each and every day toward a 100% cure rate of brain cancer, which kills more children than any other disease.
A recipient of a Perth Children’s Hospital Foundation research grant, Dr Gottardo is a world leader in paediatric oncology (read: kids’ cancer) and is working hard to find a cure for Medulloblastoma: the most common brain cancer in children.
Nick and his research team are working to identify drugs that when combined with radiotherapy or chemotherapy will kill brain tumour cells more effectively and reduce the often serious side effects of treatment.
Through his extensive research, and thanks to Perth Children’s Hospital Foundation donors, Dr Gottardo is on track to launch a clinical world trial for a drug known as a cell cycle checkpoint kinase inhibitor. His research has shown that this drug makes radiotherapy and chemotherapy more effective for children suffering Medulloblastoma. The results of this trial could be momentous for children suffering from this disease.